Skip to content
DefDex

Federal award

DMS PHARMACEUTICAL GROUP INC

SPE2DB22FZW06

Contract

Obligated and Ceiling

Obligated (net)
$10,274.04
Ceiling (potential value, not spending)
$10,274.04
Current value
$10,274.04
Gross positive obligations
$10,274.04

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
DMS PHARMACEUTICAL GROUP INC · PX72BSBQTKJ3
Owner company
DMS Pharmaceutical GroupBasis direct: the recipient is the company's own reviewed UEI.
Reported parent
DMS PHARMACEUTICAL GROUP INC · PX72BSBQTKJ3
Awarding agency
Department of Defense · sub-agency 97AS · office SPE2DB
Funding agency
Department of Defense · sub-agency 97AS
Product or service (PSC)
6505 · DRUGS AND BIOLOGICALS
Industry (NAICS)
424210 · DRUGS AND DRUGGISTS' SUNDRIES MERCHANT WHOLESALERS
PIID
SPE2DB22FZW06
Parent vehicle (IDV PIID)
SPE2DB20D9135
Award type code
C
Actions
1 · Sep 1, 2022 to Sep 1, 2022
Why it is listed
reviewed company, $10k or more

Open this award on USAspending →

Action History1

Award actions
DateFYModAction typeObligationCompany in company totals
Sep 1, 2022FY20220—$10,274.04

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.